IceCure Highlights Cryoablation Advances in Breast Cancer Care
Caesarea, Israel, August 13, 2026 IceCure Medical Ltd., a developer of minimally invasive cryoablation technology for tumor treatment, has...
Tumor Ablation
Advertisement
IceCure Seeks NCCN Support for Breast Cancer Cryoablation
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
IceCure Expands ProSense Cryoablation in Brazil After FDA Clearance
CAESAREA, Israel, July 6, 2026 IceCure Medical Ltd. has announced accelerating commercial adoption of its ProSense™ cryoablation system in...
IceCure Wins Israel Approval for XSense™ Cryoablation System
CAESAREA, Israel, Sept. 15, 2025 – IceCure Medical Ltd. (NASDAQ: ICCM), a pioneer in minimally invasive cryoablation therapies, today...
Advertisement
